North Carolina Hematologic Malignancies Symposium 2026: Evidence-Based Updates and Clinical Decision-Making in Lymphoma, CLL, Myeloma, AML, and MPNs

Official conference page for North Carolina Hematologic Malignancies Symposium 2026: Evidence-Based Updates and Clinical Decision-Making in Lymphoma, CLL, Myeloma, AML, and MPNs. https://binaytara.org/projects/conferences/north-carolina-hematologic-malignancies-symposium

About North Carolina Hematologic Malignancies Symposium 2026: Evidence-Based Updates and Clinical Decision-Making in Lymphoma, CLL, Myeloma, AML, and MPNs

Overview

Target AudienceLearning Objectives

Trusted by Thousands of Attendees
Across Our Events

Email if you have questions

Faculty and committee

Our Speakers

View all disclosures

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binayatara